When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HALO - Halozyme inks Enhanze deal with NIH unit in HIV
Halozyme Therapeutics Inc.
Halozyme (HALO+1.4%) enters into an agreement with the NIH's National Institute of Allergy and Infectious Diseases' Vaccine Research Center aimed at leveraging HALO's ENHANZE drug delivery technology to develop subcutaneous formulations of broadly neutralizing antibodies against HIV.
More news on: Halozyme Therapeutics, Inc., Healthcare stocks news, Stocks on the move,